Author Guidelines

Updated: 13/9/2026

1. Scope and General Policy

The Journal of Basic and Applied Research in Biomedicine (jbarbiomed) publishes original research, reviews, and short communications across biomedical, medical, dental, pharmaceutical, biological, and nutritional sciences. All editorial decisions are made independently of commercial interests, in line with the ICMJE Recommendations, the COPE Core Practices, and the Principles of Transparency and Best Practice in Scholarly Publishing (COPE/DOAJ/OASPA/WAME).

Before submitting, please confirm:

  • The manuscript falls within the journal’s scope.
  • The work has not been published previously and is not under consideration elsewhere (including no substantial overlap with a prior publication in any language).
  • All authors have read, approved, and take responsibility for the final version.
  • Any prior presentation (conference abstract, thesis chapter, preprint) is disclosed in the cover letter.
  • If the manuscript was posted as a preprint, the preprint server and DOI are disclosed; this does not preclude consideration for publication.

 

2. Authorship and Contributorship

Authorship must be based on all four ICMJE criteria:

  1. Substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data;
  2. Drafting the work or revising it critically for important intellectual content;
  3. Final approval of the version to be published;
  4. Agreement to be accountable for all aspects of the work, ensuring questions related to accuracy or integrity are appropriately investigated and resolved.

Individuals who contributed but do not meet all four criteria (e.g., data collection only, supervision without drafting, general supervision of a lab, language editing, statistical consultation) should be listed in the Acknowledgements, not as authors, with their consent.

Corresponding author responsibilities: The corresponding author is the point of contact during submission, review, and post-publication, and confirms that:

  • all listed individuals meet authorship criteria and no eligible contributor has been omitted (no ghost authorship);
  • no individual who does not meet the criteria has been included (no guest/honorary authorship);
  • the final manuscript has been seen and approved by all co-authors before submission and before any post-acceptance revision.

Author identification:

  • An ORCID iD is required for the corresponding author and strongly encouraged for all co-authors. This is now standard practice for Crossref/Scopus/Web of Science author disambiguation and will be requested at submission.
  • Institutional affiliations should use the full standard name of the institution (not only an acronym), so affiliations can be independently verified.

Contribution statement (CRediT): Please provide an author contribution statement using the CRediT taxonomy (Conceptualization; Methodology; Software; Validation; Formal analysis; Investigation; Resources; Data Curation; Writing – Original Draft; Writing – Review & Editing; Visualization; Supervision; Project Administration; Funding Acquisition), e.g.:

AB: Conceptualization, Methodology, Writing – Original Draft. CD: Formal analysis, Investigation. EF: Supervision, Writing – Review & Editing.

Free-text contribution paragraphs (e.g., “X and Y designed the work; Z drafted the manuscript”) are also acceptable but CRediT labels are preferred and will become the house style.

 

3. Ethical Oversight

Full ethics requirements (approving-body statements, consent wording, IACUC compliance) are set out on the Journal Policies page under “Human and Animal Studies” — follow that wording for your Methods-section declaration. In addition to that baseline, for manuscript preparation please also note:

  • Human research: Written informed consent must be obtained from participants (or legal guardians for minors). If any individual is identifiable in text, images, or case details, include a separate statement that consent to publish was obtained.
  • Animal research: Must be reported in accordance with the ARRIVE 2.0 guidelines, in addition to the IACUC approval statement required by Journal Policies.
  • Clinical trials: Must be registered in a publicly accessible trials registry (e.g., ClinicalTrials.gov, PACTR, CTRI) before enrollment of the first participant, per ICMJE policy. State the registry name and trial registration number in the abstract and Methods. Trial reports should follow CONSORT.
  • Systematic reviews/meta-analyses should follow PRISMA 2020 and, where applicable, be prospectively registered (e.g., PROSPERO).
  • Observational studies (cohort, case-control, cross-sectional) should follow STROBE.
  • Case reports should follow CARE guidelines and include an explicit statement on consent to publish identifiable participant details/images.

A completed reporting-guideline checklist (ARRIVE/STROBE/CONSORT/PRISMA/CARE as applicable) should be uploaded as a supplementary file at submission.

Sex and gender reporting: Where relevant, authors should report the sex and/or gender of study participants or animal subjects and state the definitions used (see the SAGER guidelines). Where sex/gender was not considered, this should be noted as a limitation.

 

4. Manuscript Preparation

  • Submit as a single Microsoft Word (.docx), OpenOffice, or RTF file. Font: Times New Roman, 12 pt, double-spaced, 2.5 cm margins on all sides, A4, one side of the page only.
  • Number all lines continuously throughout the manuscript.
  • Number all pages.
  • Insert tables and figures within the text at the point they are first cited (not grouped at the end).

Manuscript sections, in order:

  1. Title page
  2. Abstract and Keywords
  3. Introduction
  4. Materials and Methods
  5. Results
  6. Discussion
  7. Conclusion
  8. Declarations (see Section 6 below: Ethics, Consent, AI use, Data Availability, Conflicts of Interest, Funding, Author Contributions, Acknowledgements)
  9. References

Title page

  • Full title (concise, specific, without unnecessary abbreviations).
  • Full names of all authors, with affiliations linked by superscript numbers.
  • ORCID iD for the corresponding author (required) and co-authors (encouraged).
  • Corresponding author’s name, institutional email, and postal address.
  • A short running title (≤ 60 characters).

Abstract

Structured, 200–250 words, under the headings Background, Objectives, Methods, Results, Conclusion.

Keywords

3–10 keywords.

Introduction

State the problem, briefly summarize relevant prior work, and end with a clear statement of the study’s objective(s) or hypothesis.

Materials and Methods

Sufficient detail for reproduction, including: study design and setting; sampling method and sample-size justification; inclusion/exclusion criteria; variables and how they were measured; statistical methods (software and version); and the ethical approvals described in Section 3.

Results

Report findings without interpretation. Use tables/figures to present numerical data rather than duplicating them at length in text. State exact p-values and effect sizes/confidence intervals where applicable, not only “p<0.05.”

Discussion

Interpret findings in light of existing literature without repeating the Results. Explicitly discuss study limitations (a required subsection) and, where relevant, generalizability.

Conclusion

Directly answer the study objective(s); avoid overreaching claims beyond what the data support.

Tables and Figures

Numbered sequentially (Table 1, Table 2…; Figure 1, Figure 2…), each with a self-explanatory title/legend so it can be understood without the main text. Define all abbreviations in a footnote.

 

5. References

  • In-text citation: author–year format, e.g., (Borges, 2010); (Borges & John, 2011); (Borges et al., 2014).
  • Reference list: alphabetical, APA style, with DOI or stable URL included wherever available.
  • Every in-text citation must correspond to exactly one reference-list entry, and vice versa — please check this before submission (duplicate or orphaned references were found in recently published issues and will now be checked at copyediting; catching this at author stage saves a production cycle).
  • Excessive self-citation or citation arranged at a reviewer/editor’s request purely to inflate metrics is not permitted (COPE citation manipulation policy).
  • Cite the most recent and relevant literature; verify that all cited works are genuine and correctly attributed (do not rely on AI tools to generate references — see Section 6.3).

 

6. Required Declarations

All manuscripts must include the following declarations, in this order, before the reference list:

Authors may copy and adapt the wording below for each declaration — pick the scenario that matches your study and fill in the bracketed details. These templates are provided to reduce ambiguity and inconsistency across submissions; they do not replace the substantive requirements in Sections 3 and 6 above.

6.1 Ethics Approval and Consent to Participate

Human research (prospective, with consent):

Ethical approval for this study was granted by [name of Ethics/IRB Committee], [Institution], and [any co-approving body, e.g., a Ministry of Health] (Approval No.: [XXX], Date: [DD Month YYYY]). Written informed consent was obtained from all participants prior to enrollment. The study conformed to the principles of the Declaration of Helsinki.

Human research (retrospective, consent waived):

This study was approved by [Ethics Committee], [Institution] (Approval No.: [XXX]), which granted a waiver of informed consent for this retrospective analysis of routinely collected/anonymized data. The study was conducted in accordance with the Declaration of Helsinki.

Animal research:

All animal procedures were approved by [Institutional Animal Care and Use Committee / Ethics Committee name], [Institution] (Approval No.: [XXX], Date: [DD Month YYYY]), and were conducted in accordance with [the National Research Council’s Guide for the Care and Use of Laboratory Animals / institutional-national guideline] and reported following the ARRIVE 2.0 guidelines.

Case report:

Ethical approval was not required for this case report per institutional policy. Written informed consent for publication of the case details was obtained from the patient (or legal guardian).

Not applicable (e.g., in vitro study with commercial cell lines, secondary/simulation analysis, methods paper, review):

Not applicable. This study did not involve human participants, human data, or animals.

6.2 Consent for Publication

Identifiable data/images present:

Written informed consent for publication of identifying information/images was obtained from the participant (or legal guardian/next of kin).

No identifiable data:

Not applicable.

6.3 Declaration of Generative AI and AI-Assisted Technologies

Not used:

The authors declare that no generative AI or AI-assisted technologies were used in the preparation of this manuscript.

Used for language editing only:

The authors acknowledge that AI-assisted technologies were partially used in the preparation of this manuscript. Specifically, [tool name, e.g., ChatGPT/Grammarly] was employed to support language refinement and grammar correction. All content was critically reviewed, edited, and approved by the authors to ensure accuracy, originality, and alignment with academic standards. No AI tools were used to generate data, interpret results, or replace the authors’ intellectual contribution.

Used more substantively (literature scoping, drafting assistance):

[Tool name] was used to assist with [literature search / initial draft outline / code debugging] during manuscript preparation. All AI-generated content was verified, revised, and approved by the authors, who take full responsibility for the accuracy and integrity of the final manuscript.

6.4 Data Availability Statement

Data in the article/supplementary files:

The data supporting the findings of this study are included within the article and its supplementary materials.

Available on reasonable request:

The data that support the findings of this study are available from the corresponding author upon reasonable request.

Deposited in a public repository:

The datasets generated and/or analyzed during this study are available in the [repository name, e.g., Zenodo/Figshare/Dryad] repository, [DOI or accession number].

Restricted (privacy/ethical constraints):

The data are not publicly available due to [privacy restrictions imposed by the ethics committee / containing information that could compromise participant privacy] but are available from the corresponding author on reasonable request and with permission of [ethics committee/institution].

Not applicable (review article, no new data generated):

Not applicable — no new data were generated or analyzed in this review.

6.5 Conflicts of Interest

None:

The authors declare no conflict of interest in this study.

Declared:

[Author A] has received funding from [Company/Organization]. [Author B] serves as a consultant for [Organization]. These relationships had no influence on the design, execution, or interpretation of the study.

6.6 Funding

No specific funding:

The authors declare that this research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

Funded:

This work was supported by [Funder Name] under Grant No. [XXX].

Self-funded (single-author or small studies):

This study was not funded by external sources aside from the author(s)’ own resources.

6.7 Author Contributions (CRediT)

Multi-author example:

AB: Conceptualization, Methodology, Writing – Original Draft. CD: Investigation, Formal analysis. EF: Supervision, Writing – Review & Editing, Funding acquisition. All authors read and approved the final manuscript.

Single-author paper:

[Author] is solely responsible for the conception, design, execution, analysis, and writing of this study, and takes full accountability for its content.

6.8 Acknowledgements

Technical/institutional support:

The authors thank [name/department] for [technical assistance / sample analysis / facilities provided].

None:

Not applicable.

 

7. Plagiarism and Similarity Screening

All submissions are screened with plagiarism-detection software prior to review, per the thresholds and two-round process set out in the Journal Policies “Plagiarism Policy.” Authors should ensure originality before submission rather than relying on the screening step to catch issues — see Section 5 above on citation practice.

 

8. Peer Review

jbarbiomed operates a double-blind peer review process; the full workflow, number of reviewers, and appeal-to-a-further-reviewer mechanism are described in the Journal Policies “Peer-review Policy.” For manuscript preparation, note that you should provide 3–5 suggested reviewers with institutional email, affiliation, and area of expertise in your cover letter; the editor is not obliged to use them and will independently verify reviewer identity and absence of conflicts of interest.

 

9. Corrections, Retractions, and Withdrawal

Post-publication corrections (erratum, corrigendum, addendum), retraction grounds, and the pre-/post-publication withdrawal process (including any applicable fee) are governed by the Journal Policies “Retraction and Correction Policy” and “Withdrawal Policy.” This page does not duplicate those terms — consult Journal Policies directly, and raise any concern about a published article with the editor at the contact address on that page.

 

10. Submission Checklist

Before submission, please confirm:

  • ☐ Manuscript is within scope and not under consideration elsewhere (or overlap is disclosed).
  • ☐ Title page includes full author list, affiliations, and corresponding author’s ORCID and email.
  • ☐ Structured abstract (Background, Objectives, Methods, Results, Conclusion), 200–250 words.
  • ☐ Ethics approval/consent statements included with approval numbers and dates (or a statement of exemption).
  • ☐ Relevant reporting-guideline checklist attached (ARRIVE/STROBE/CONSORT/PRISMA/CARE).
  • ☐ All declarations in Section 6 are present.
  • ☐ References are complete, correctly matched to in-text citations, and include DOIs where available.
  • ☐ Manuscript formatted per Section 4 (double-spaced, 12 pt Times New Roman, continuous line numbers).
  • ☐ Cover letter and Copyright Transfer Agreement form attached.
  • ☐ 3–5 suggested reviewers provided, with email, affiliation, and expertise.

Submit online via the journal’s submission system, or email the manuscript, cover letter, and License to Publish Agreement to jbaarsubmit@gmail.com.